PART I. Answer Questions 1-10 with reference to TEXT 1 that follows. Only one option is correct for each question.
|
|
- Myles Harris
- 5 years ago
- Views:
Transcription
1
2 PART I Answer Questions 1-10 with reference to TEXT 1 that follows. Only one option is correct for each question. 1. The title of the article: A. suggests that influenza is no longer a major public health problem B. questions whether anyone really cares about contracting the H1N1 virus C. implies that no-one knows who is responsible for the spread of influenza D. makes reference to the efforts being made by the World Health Organisation to control influenza 2. Which of the following pieces of information is NOT to be found in the second paragraph? A. A long-term strategy for bringing down the numbers of people who become sick and die as a result of influenza has yet to be developed. B. There were four worldwide outbreaks of influenza in the 20 th century, which killed over 50,000,000 individuals. C. The elderly with a current population of more than 380,000,000 are more likely to die as a result of contracting influenza. D. A very large number of people around the world especially in poorer countries have not heard of the influenza vaccine or are unable to obtain it. 3. The word milestone in the first sentence of the third paragraph suggests that the Global Agenda on Influenza: A. is still far from achieving its goals B. is only a preliminary step towards containing this disease C. may prove to be a crucial step towards containing the disease D. aims to achieve its goals by way of roadside vaccination centres 4. The stakeholders referred to in line 4 of paragraph 3 are: A. people who own shares in pharmaceutical companies B. people from various sectors of society with an interest in influenza C. people who have staked everything on finding a cure for influenza D. people who understand what is at stake when it comes to influenza pandemics 5. funding is limited in line 6 of paragraph 3 means: A. not much is known B. work has barely begun C. not much money is available D. there is not much interest 1
3 6. vaccines are grossly underused in lines 6-7 of paragraph 3 means: A. mass vaccination has already been carried out B. it is shocking how few people know how to use vaccines properly C. vaccination is a crude and relatively ineffective measure D. vaccines are employed a lot less than they should be 7. Moreover in the penultimate line of paragraph 3 could be replaced by A. Similarly B. Yet C. However D. Furthermore 8. The fourth paragraph tells us that: A. all those taking part in a WHO consultation in May 2002 agreed with the agenda B. only four of a total of 17 priorities are going to be addressed C. Gro Harlem Brundtland criticizes the decision of the WHO to focus only on its existing strengths D. the global agenda does not provide unbiased orientation on influenza control 9. If you wish to consult the full text of the Global Agenda on Influenza you should: A. order a copy on the Internet B. buy the book referenced in the footnote C. visit the website given at the end of the text D. be a registered physician and first obtain permission from the Director General 10. This text was probably written: A. to respond to the recent H1N1 outbreak B. shortly after the WHO consultation mentioned in the text C. to address the concerns of the general public regarding a major influenza pandemic D. towards the end of the 20 th century 2
4 TEXT 1 Influenza WHO cares This summer, the WHO put together an historic document: the first Global agenda on Influenza Surveillance, Prevention and Control.[1] Why is this so important? This is the first time that a strategic roadmap has been developed containing long-term priorities to reduce morbidity and mortality from annual influenza epidemics and to prepare for the next influenza pandemic. During the influenza epidemics every year, an estimated half a million people worldwide die. The four pandemics in the last century alone claimed more than 50 million lives. In 2001, only 250 million vaccine doses were used globally, whereas the people at greatest risk of dying from influenza those aged over 65 already number more than 380 million. The vast majority of people, particularly, but not exclusively, those in developing countries, have no access to the vaccine or are unaware of the benefits of vaccination. The Global Agenda on Influenza could become a milestone in influenza control. Although the WHO Global Influenza Programme initiated the work on the Global Agenda, it was developed through a consultative and transparent process involving stakeholders from ministries of health, academia, non-governmental organisations, and the pharmaceutical industry. Collaboration, vision, and leadership are critical in influenza control where funding is limited for research and development, vaccines are grossly underused, and attention is almost exclusively focusing on developed countries. This focus is surprising given the clear evidence of the clinical importance of influenza in developing countries. Moreover, an influenza pandemic will have its greatest impact on developing countries where there is no vaccine and antiviral production. The Global Agenda, which was endorsed by the more than 60 participants during a consultation at WHO on May 6 7, 2002, contains 17 priority actions focusing on four major themes: (1) strengthen disease and virological surveillance nationally and internationally; (2) increase knowledge on the health and economic burden of influenza; (3) increase influenza vaccine usage; and (4) accelerate national and international action on pandemic preparedness. In opening the consultation, Gro Harlem Brundtland, Director General of WHO, stressed the importance to WHO of the Global Agenda for focusing on what we do best. As important, the Global Agenda shows the way for all those who need impartial guidance on priorities for research and development and national/global action for influenza control. It will also help to support fund raising for influenza control at national and international levels. The WHO Global Influenza Programme intends to maintain the current momentum of international strategy development and will continue to provide leadership in influenza prevention and control. The Global Agenda and further information can be found at: References 1 WHO Global Influenza Programme. (accessed Aug 6, 2002). THE LANCET Infectious Diseases Vol 2 September
5 PART 2 Answer Questions with reference to TEXT 2 that follows. Only one option is correct for each question. 11. Which of the following statements is true? A. The word issues in the title could be replaced by editions B. The word safety in the title could be replaced by security C. The word supply in the title could be replaced by provision D. The word surrounding in the title could be replaced by embracing 12. The phrase several thorny issues in the first paragraph could be replaced by: A. serious hard challenges B. many crafty questions C. a few difficult matters D. a number of challenging problems 13. Which of the following pieces of information is TRUE according to the second paragraph? A. Clever people also believe that people should take an extra two doses of the vaccine on top of the one already recommended. B. Every country will need the vaccine, although, at present it is not possible to produce it in sufficient quantities worldwide to satisfy this demand. C. Health professionals warn that taking two doses of the vaccine will reduce its potency. D. Some companies are trying to find a way of developing the vaccine using crop seed. 14. It can be understood from the third paragraph that adjuvants are: A. substances added to the vaccine to enhance its effectiveness B. members of the public who volunteer to help distribute the vaccine C. likely to be viewed as necessary and effective by the United States FDA D. reduced dosages of vaccine that may prove to be dangerous and ineffective 15. Might in the third line of paragraph 4 could be replaced by: A. must B. should C. could D. ought to be 4
6 16. Therefore in paragraph 4 line 4 could be replaced by: A. likewise B. nevertheless C. thus D. so 17. The word some in paragraph 4 line 5 refers to: A. complications B. apprehensions regarding the vaccination campaign C. post-marketing surveillance D. an unspecified number of people 18. In 1976: A. vaccination was ineffective because it was not carried out on a large enough scale B. there were fears of a repeat of the H1N1 pandemic C. the campaign was discontinued as the vaccine had to be removed from circulation D. the vaccine had to be withdrawn from those who had received it 19. The overall context of the article leads one to understand that rolling out in the last paragraph means: A. presenting a product to the public for the first time B. introducing a product in a series of stages, each involving increasingly broader coverage C. withdrawing a product in a series of stages, each involving increasingly narrower coverage D. removing a product from its casing by flattening it 20. This text was probably written: A. by the FDA, to counter misconceptions regarding the efficacy of the influenza vaccine B. to address recent developments in the worldwide response to the H1N1 outbreak C. to quell widespread panic among the general public with regard to a major influenza pandemic D. last week 5
7 TEXT 2 Supply and safety issues surrounding an H1N1 vaccine Last week, Australia and the USA announced that they would begin trials of an H1N1 vaccine. Vaccination against H1N1 will be an important development in controlling the impact of the pandemic. However, several thorny issues exist around vaccine manufacture and approval. All countries will require the vaccine but current global manufacturing capacity will not be able to meet this demand. Additionally, experts think that individuals might need two doses of the vaccine instead of one, reducing capacity further. Vaccine manufacturers are also struggling to produce good vaccine yields with the H1N1 seed virus. One way to ease these supply problems is the use of adjuvants in a vaccine. On July 7, WHO s Strategic Advisory Group of Experts on Immunization recommended that vaccine formulated with oil-in-water adjuvants and live-attenuated influenza vaccines should be promoted to help increase the global supply of a vaccine and because they are better at protecting against strain variations. Yet there are signs that the USA might not follow this recommendation. Adjuvant use would be contingent upon showing that it was needed or clearly beneficial, Jesse Goodman, acting chief scientist and deputy commissioner of the Food and Drug Administration told a press briefing on July 17. The USA must support the use of dose-sparing strategies to avoid depletion of an already short vaccine supply. As well as availability, safety of an H1N1 vaccine is a concern. Many national regulatory agencies have set up fast-track approval processes for the H1N1 vaccine, which means that a vaccine might be licensed without the usual safety and efficacy data requirements. Vaccine safety will therefore have to be monitored through postmarketing surveillance. But some fear a repeat of the 1976 H1N1 outbreak in the USA, where mass vaccination was associated with complications, which stopped the campaign and led to the withdrawal of the vaccine. Countries need to assess carefully the risks and benefits of rapid approval of an H1N1 vaccine, especially since the disease has so far been mild with most patients making a full recovery. They must also ensure that they have strong post-marketing surveillance in place before rolling out a vaccine. The Lancet 6
8 Centro de Pesquisas AGGEU MAGALHÃES Prova de ingles Quinta feira dia 29 de outubro de h00 12h00 MESTRADO ACADÊMICO EM SAÚDE PÚBLICA 2010 ( ) MESTRADO PROFISSIONAL EM SAÚDE PÚBLICA 2010 ( ) Nome de candidato: RG de candidato: TEXT 1 TEXT 2 Question Answer Question Answer 1 A B C D 11 A B C D 2 A B C D 12 A B C D 3 A B C D 13 A B C D 4 A B C D 14 A B C D 5 A B C D 15 A B C D 6 A B C D 16 A B C D 7 A B C D 17 A B C D 8 A B C D 18 A B C D 9 A B C D 19 A B C D 10 A B C D 20 A B C D 7
9 Gabarito 1 D 11 C 2 A 12 D 3 C 13 B 4 B 14 A 5 C 15 C 6 D 16 C 7 D 17 D 8 A 18 C 9 C 19 B 10 B 20 B 8
PART I. Answer Questions 1-10 with reference to TEXT 1 that follows. Only one option is correct for each question.
PART I Answer Questions 1-10 with reference to TEXT 1 that follows. Only one option is correct for each question. 1. The title of the text: A. queries how much effort is being spent on containing swine
More information7th Mena Influenza Stakeholders Meeting. WHO Influenza Strategy Development and Vaccine-related Research Priorities
7th Mena Influenza Stakeholders Meeting WHO Influenza Strategy Development and Vaccine-related Research Priorities Wenqing Zhang 9 10 September 2017 Riga, Latvia 1 Seasonal influenza 1 billion cases yearly
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT. Vaccination strategies against pandemic (H1N1) 2009.
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 15.9.2009 SEC(2009) 1189 final COMMISSION STAFF WORKING DOCUMENT Vaccination strategies against pandemic (H1N1) 2009 accompanying the COMMUNICATION FROM
More informationWHO GLOBAL ACTION PLAN FOR INFLUENZA VACCINES
WHO GLOBAL ACTION PLAN FOR INFLUENZA VACCINES SURVEY QUESTIONNAIRE A.1. Introduction The Global Action Plan for Influenza Vaccines (GAP) was launched in 2006 as a ten year initiative to address the anticipated
More informationNova Scotia s Response to H1N1. Summary Report
Nova Scotia s Response to H1N1 Summary Report December 2010 H1N1 Summary Report l 1 Introduction In April 2009, an outbreak of a new virus called H1N1 influenza was identified in Veracruz, Mexico. As the
More informationFINAL RECOMMENDATIONS ON PANDEMIC INFLUENZA
Comprehensive Family Immunization Family and Community Health Area FINAL RECOMMENDATIONS ON PANDEMIC INFLUENZA TECHNICAL ADVISORY GROUP ON VACCINE-PREVENTABLE DISEASES 24-26 AUGUST 2009, COSTA RICA Epidemiological
More informationPage 1 of 5 For Immediate Release Office of the Press Secretary July 17, 2007 Fact Sheet: Implementation of the National Strategy for Pandemic Influenza A One-Year Summary Of Efforts To Better Protect
More informationCholera. Report by the Secretariat
EXECUTIVE BOARD EB128/13 128th Session 9 December 2010 Provisional agenda item 4.10 Cholera Report by the Secretariat 1. In May 2010, the Executive Board at its 127th session considered a report on cholera
More informationAvian Influenza A(H7N9) Overview
Avian Influenza A(H7N9) Overview Side event organized by China and WHO 21 May 2013 1 Avian Influenza A(H7N9) Novel Coronavirus (ncov) World experiencing emergence of 2 exceptional new virus infections
More informationPandemic Influenza Preparedness
Pandemic Influenza Preparedness Of the many health threats that we are preparing for, this is the one that we know will happen. Bruce G. Gellin, MD, MPH Director, National Vaccine Program Office Department
More informationIMPLEMENTATION OF THE NAGOYA PROTOCOL AND PATHOGEN SHARING: PUBLIC HEALTH IMPLICATIONS
CBD Distr. GENERAL UNEP/CBD/NP/COP-MOP/2/INF/12 6 December 2015 ENGLISH ONLY CONFERENCE OF THE PARTIES TO THE CONVENTION ON BIOLOGICAL DIVERSITY SERVING AS THE MEETING OF THE PARTIES TO THE NAGOYA PROTOCOL
More informationAccess to clinical trial information and the stockpiling of Tamiflu. Department of Health
MEMORANDUM FOR THE COMMITTEE OF PUBLIC ACCOUNTS HC 125 SESSION 2013-14 21 MAY 2013 Department of Health Access to clinical trial information and the stockpiling of Tamiflu 4 Summary Access to clinical
More informationGuideline for the Surveillance of Pandemic Influenza (From Phase 4 Onwards)
Guideline for the Surveillance of Pandemic Influenza (From Phase 4 Onwards) March 26, 2007 Pandemic Influenza Experts Advisory Committee 31 Guidelines for the Surveillance of Pandemic Influenza From Phase
More informationStandardization for Preclinical Evaluation of Influenza Vaccines in Animal Models - WHO activities
Standardization for Preclinical Evaluation of Influenza Vaccines in Animal Models - WHO activities 2 nd WHO Integrated Meeting on development and clinical trials of Influenza vaccines that induce broadly
More informationAntimicrobial resistance Fact sheet N 194 Updated April 2014
Antimicrobial resistance Fact sheet N 194 Updated April 2014 Key facts Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by
More informationH1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009
August 6, 2009 H1N1 Vaccine Based on CDCs ACIP Meeting, July 29, 2009 CDC s Advisory Committee on Immunization Practices (ACIP), a panel made up of medical and public health experts, met July 29, 2009,
More informationDCVMN Perspective: Barriers and how developing countries manufacturers will be able to reach goal.
DCVMN Perspective: Barriers and how developing countries manufacturers will be able to reach goal. Dr. Suresh Jadhav Executive Director Serum Institute of India Limited. ssj@seruminstitute.com H1N1 Pandemic:
More informationInfluenza. Influenza vaccines (WHO position paper) Weekly Epid. Record (2005, 80: ) 287
Program Management 82_19 SAGE encouraged all countries to consider their preparedness for a potential influenza pandemic, recognizing that it would occur before strain-specific vaccine can be made in significant
More informationBriefing Note for the PIP Advisory Group Special Session October 2015
Briefing Note for the PIP Advisory Group Special Session 13-14 October 2015 Table of Contents Background... 2 Framework Components... 2 PIP Framework implementation progress to date... 3 Virus sharing...
More informationBefore and during influenza pandemics
before and during influenza pandemics Klaus Stöhr Department for Communicable Diseases Surveillance and Response Before and during influenza pandemics Before pandemics: interpandemic period New human influenza
More informationCHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer
CHE8000 Major Research Project A The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer Completed by: Lina Karlina (ID: 2067226) Lina Karlina (2067226)
More informationPlanning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response
Planning for Pandemic Influenza in York County: Considerations for Healthcare and Medical Response York County Pandemic Influenza Stakeholders Village by the Sea, Wells, Maine 8 August 2006 Steven J Trockman,
More informationUK Pandemic Preparedness A Cross-government Approach. Jo Newstead Legal and International Manager Pandemic Influenza Preparedness Programme
UK Pandemic Preparedness A Cross-government Approach Jo Newstead Legal and International Manager Pandemic Influenza Preparedness Programme Overview The importance of a cross-government approach for the
More informationChapter 16: Health Sector Planning and Preparedness
Pandemic Influenza Plan for the Health Sector in Peel - 2007 Chapter 16: Health Sector Planning and Preparedness Continuity of Operations Planning Continuity of Operations planning, sometimes referred
More informationPandemic Influenza Preparedness and Response
24 th Meeting of Ministers of Health Dhaka, Bangladesh, 20-21 August 2006 SEA/HMM/Meet.24/4(b) 10 July 2006 Pandemic Influenza Preparedness and Response Regional situation: Human cases and outbreaks of
More informationPandemic Preparedness Communications: WHO
Pandemic Preparedness Communications: WHO International Ministerial Conference on Avian and Pandemic Influenza, New Delhi, 5 December 2007 WHO Strategic Action Plan: 5 key areas that concern human health
More informationCopenhagen, Denmark, September August Malaria
Regional Committee for Europe 64th session EUR/RC64/Inf.Doc./5 Copenhagen, Denmark, 15 18 September 2014 21 August 2014 140602 Provisional agenda item 3 ORIGINAL: ENGLISH Malaria Following the support
More informationPandemic Influenza Cross Sectoral Preparedness and Planning
Opening statement Seminar on Pandemic Influenza Cross Sectoral Preparedness and Planning Ministry of Health and Care Services, Oslo 19. February 2009 State secretary Rigmor Aasrud Dear speakers, dear participants,
More informationGOVERNMENT OF ALBERTA. Alberta s Plan for Pandemic Influenza
GOVERNMENT OF ALBERTA Alberta s Plan for Pandemic Influenza November 2003 What is pandemic influenza? The word pandemic is used to describe diseases that cause worldwide outbreaks of illness involving
More informationGlobal Challenges of Pandemic and Avian Influenza. 19 December 2006 Keiji Fukuda Global influenza Programme
Global Challenges of Pandemic and Avian Influenza 19 December 2006 Keiji Fukuda Global influenza Programme Summary of Current H5N1 Situation 1997 First known outbreak infecting humans 18 people hospitalized
More informationGuideline for Antiviral Drugs
Guideline for Antiviral Drugs March 26, 2007 Pandemic Influenza Experts Advisory Committee 179 180 Guideline for Antiviral Drugs Distribution adjustment Before outbreak occurs in Japan Instruct medical
More informationELECTRONIC IMMUNISATION RECORD
ELECTRONIC IMMUNISATION RECORD SPECIAL REPORT 6-12 OCTOBER 2017 http://eurac.tv/9abu With the support of ELECTRONIC IMMUNISATION RECORD SPECIAL REPORT 6-12 OCTOBER 2017 http://eurac.tv/9abu Contents Commission
More informationIntercell and Novartis form world leading strategic partnership to drive vaccines innovation
Intercell and Novartis form world leading strategic partnership to drive vaccines innovation Alliance creates opportunity for two strong innovators to combine development efforts in attractive areas Intercell
More informationSubmitted to the House Energy and Commerce Committee. Federal Efforts to Combat the Opioid Crisis
STATEMENT FOR THE RECORD Submitted to the House Energy and Commerce Committee Federal Efforts to Combat the Opioid Crisis October 25, 2017 America s Health Insurance Plans 601 Pennsylvania Avenue, NW Suite
More informationGlobal pandemic preparedness and response: a 10-year horizon for strengthened capacities
Advisory Group Recommendations to the Director-General on Potential uses of PIP Partnership Contribution resources for pandemic preparedness and response On behalf of the Advisory Group, its Chair has
More informationPandemic lessons learnt
Pandemic lessons learnt PCWP-HCPWG Joint meeting 28 February 2012 Presented by: Ragini Shivji, Monika Benstetter EMA An agency of the European Union Overview of presentation Background & Objective European
More informationPartnership Contribution Standard Operating Procedures June 2015
Partnership Contribution Standard Operating Procedures June 2015 This document replaces the version dated May 2013 In May 2011, the Sixty- fourth World Health Assembly adopted the Pandemic Influenza Preparedness
More information1 A 2 D 3 D 4 D 5 D 6 D 7 B 8 A 9 B 10 C 11 B 12 B 13 C 14 B 15 C 16 A 17 A 18 A 19 B 20 D
MESTRADO ACADÊMICA SAÚDE PÚBLICA TURMA 2011 GABARITO OFICIAL DA PROVA DE INGLÊS 1º ETAPA DA SELEÇÃO 1 A 2 D 3 D 4 D 5 D 6 D 7 B 8 A 9 B 10 C 11 B 12 B 13 C 14 B 15 C 16 A 17 A 18 A 19 B 20 D Av. Professor
More informationMulti-sectoral aspects of pandemic preparedness and response
Multi-sectoral aspects of pandemic preparedness and response Best practices, challenges and lessons learned in the EU International Ministerial Conference on Avian & Pandemic Influenza Sharm el Sheikh,
More informationGaps in Influenza Clinical Research. Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program
Gaps in Influenza Clinical Research Presented by: Dr Gina Samaan Technical Officer, Indonesia Field Epidemiology Training Program Outline 1. Global frameworks: 2010 Research Agenda 2013 BRaVe Agenda 2.
More informationPANDEMIC INFLUENZA PLAN
PANDEMIC INFLUENZA PLAN August 13, 2009 Credits: We wish to acknowledge and thank Saskatoon Public Schools for their willingness to share information which served as the basis for this document. 1 Pandemic
More informationH1N1 Planning, Response and Lessons to Date
H1N1 Planning, Response and Lessons to Date Glen Nowak, Ph.D. Acting Director Division of News and Electronic Media Centers for Disease Control and Prevention The Beginning Mid-April indications that we
More informationUpdate on A(H1N1) pandemic and seasonal vaccine availability. July 7, 2009
Update on A(H1N1) pandemic and seasonal vaccine availability July 7, 2009 Presentation objectives and approach Presentation Objectives Review production status for 2009-2010 Northern Hemisphere vaccine
More informationInfluenza: The Threat of a Pandemic
April, 2009 Definitions Epidemic: An increase in disease above what you what would normally expect. Pandemic: A worldwide epidemic 2 What is Influenza? Also called Flu, it is a contagious respiratory illness
More informationPandemic Influenza Preparedness and Response
Pandemic Influenza Preparedness and Response US Department of Health and Human Services Bruce Gellin, MD, MPH Director, National Vaccine Program Office The pandemic influenza clock is ticking. We just
More information1. Avian Influenza H5N1 had not occurred in Malaysia until the first case of
INTERVENTION NOTES BY H.E. AMBASSADOR HAMIDON ALI, PERMANENT REPRESENTATIVE OF MALAYSIA TO THE UNITED NATIONS AT THE SPECIAL EVENT ON THE THEME OF AVIAN FLU, ORGANIZED BY THE ECONOMIC AND SOCIAL COUNCIL
More informationLinking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning
Linking Pandemic Influenza Preparedness with Bioterrorism Vaccination Planning APHA Annual Meeting San Francisco, California Lara Misegades, MS Director of Infectious Disease Policy November 18, 2003 Overview
More informationSecond intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network
Summary report on the Second intercountry meeting on the Eastern Mediterranean Acute Respiratory Infection Surveillance (EMARIS) network WHO-EM/CSR/070/E Sharm el-sheikh, Egypt 24 27 November 2013 Summary
More informationGlobal Health Security and Domestic Preparedness:
Centers for Disease Control and Prevention Robert R. Redfield, MD Director, Centers for Disease Control and Prevention Global Health Security and Domestic Preparedness: Public Health in an Insecure World
More informationPandemic Influenza Preparedness Framework. Sharing influenza viruses & access to vaccines and other benefits
Pandemic Influenza Preparedness Framework Sharing influenza viruses & access to vaccines and other benefits What is PIP? Landmark, innovative public health arrangement to increase global preparedness to
More informationThe role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods
The role of National Influenza Centres (NICs) during Interpandemic, Pandemic Alert and Pandemic Periods INTRODUCTION National Influenza Centres (NICs) are the backbone of the WHO Global Influenza Surveillance
More informationPandemic (H1N1) 2009 influenza vaccination in the EU
Pandemic (H1N1) 2009 influenza vaccination in the EU Dr Antoon Gijsens Unit C3 - Health Threats Directorate C - Public Health and Risk Assessment Directorate-General for Health & Consumers Luxembourg,
More informationA conversation with Michael Osterholm on July 30, 2013 about pandemics
A conversation with Michael Osterholm on July 30, 2013 about pandemics Participants Michael Osterholm Director, Center for Infectious Disease Research and Policy (CIDRAP), University of Minnesota Alexander
More informationWHOLE OF - SOCIETY PANDEMIC READINESS
WHOLE OF - SOCIETY PANDEMIC READINESS May 7, 2009 9AM Nairobi, Kenya Dr Liviu Vedrasco vedrasco@un.org Pandemic Influenza Coordination Team (PIC) UN Office for the Coordination of Humanitarian Affairs
More informationH1N1 Disease & Vaccine in Maryland
H1N1 Disease & Vaccine in Maryland A Webcast for Registered Vaccine Providers October 22, 2009 E-mail Questions to: maphtc@jhsph.edu 1 Program & Panel Presenters Introductory Remarks:- John M. Colmers,
More informationGENERAL SAFETY ISSUES September 18, 2009
Is the 2009 H1N1 influenza vaccine safe? GENERAL SAFETY ISSUES September 18, 2009 We expect the 2009 H1N1 influenza vaccine to have a similar safety profile as seasonal flu vaccines, which have a very
More informationReport to the. GAVI Alliance Board June 2013
Report to the GAVI Alliance Board 11-12 June 2013 Subject: Report of: Authored by: Risk Management Update Helen Evans, Deputy CEO Ciara Goldstein, Analyst, Performance Management and Adrien de Chaisemartin,
More informationAnti-HIV treatments information
PROJECT NASAH BRIEFING SHEET 1 Anti-HIV treatments information NAM, the National AIDS Trust, Sigma Research and the African HIV Policy Network have conducted research into the treatment information needs
More informationGlobal Pandemic Preparedness Research Efforts. Klaus Stöhr. WHO Global Influenza Programme. Today
Global Pandemic Preparedness Research Efforts Klaus Stöhr 3 Today Medium-term applied research linked to medical and public health interventions addressing the current pandemic situation in Asia Natural
More informationPANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES
PANDEMIC INFLUENZA PREPAREDNESS: STATE CHALLENGES A Presentation to the Council of State Governments Health Policy Forum by Jeffrey Levi, Ph.D., Executive Director Trust for America s Health June 23, 2006
More informationNational Dementia Vision for Wales Dementia Supportive Communities
National Dementia Vision for Wales Dementia Supportive Communities Crown Copyright 2011 WAG11-11223 F641 Introduction In Wales, we are justifiably proud of the communities we have built, just as we are
More informationUpdate of The National Vaccine Plan
Update of The National Vaccine Plan Raymond A. Strikas, MD National Vaccine Program Office Department of Health and Human Services Presentation Outline Statutory basis for the National Vaccine Program
More informationPandemic Influenza: Considerations for Business Continuity Planning
Pandemic Influenza: Considerations for Business Continuity Planning Maine Telecommunications Users Group (MTUG) VTEC, South Portland, ME 10 October 2006 Steven J. Trockman, MPH Joshua C. Frances, NREMT-I
More informationAVIAN INFLUENZA. Frequently Asked Questions and Answers
PENINSULA HEALTH AVIAN INFLUENZA Frequently Asked Questions and Answers Q. What is avian influenza? Answer: Avian influenza is an infectious disease of birds caused by type A strains of the influenza virus.
More informationReport to the Board 6-7 June 2018
6-7 June 2018 SUBJECT: VACCINE INVESTMENT STRATEGY: SHORT LIST Agenda item: 07 Category: For Decision Section A: Introduction This report presents outcomes of the Phase II analyses for the Vaccine Investment
More informationThe Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework
The Inclusion of Seasonal Influenza Viruses and Genetic Sequence Data (GSD) in the Context of the Pandemic Influenza Preparedness (PIP) Framework A position paper from the Directors of the GISRS WHO Collaborating
More informationWORLD HEALTH ORGANIZATION. Revision of the International Health Regulations
FIFTY-SIXTH WORLD HEALTH ASSEMBLY - GENEVA, 19-28 MAY 2003 ASSEMBLY DOCUMENTS A56/48 - Revision of the International Health Regulations WORLD HEALTH ORGANIZATION FIFTY-SIXTH WORLD HEALTH ASSEMBLY A56/48
More informationCore Standard 24. Cass Sandmann Emergency Planning Officer. Pat Fields Executive Director for Pandemic Flu Planning
Trust Board Meeting Agenda Item 7 Date: 30 September 2009 Title of Report Recommendations (please outline the purpose of the report and the key issues for consideration/decision) Progress with Pandemic
More informationFinancing Influenza Vaccine R&D
Financing Influenza Vaccine R&D WHO GAP-II Geneve, Switzerland July 13, 2011 Robin Robinson, Ph.D. Deputy Assistant Secretary & Director HHS/ASPR/BARDA 0 Vaccine Development is Risky, Lengthy, & Expensive
More informationWORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network
WORLD BANK RESPONSE TO INFLUENZA A(H1N1) Rakesh Nangia Director, Strategy & Operations Human Development Network Tokyo, July 2009 World Bank Response to A(H1N1) Influenza A(H1N1) Global Health and Risks
More informationMessage from. Dr Samlee Plianbangchang Regional Director, WHO South-East Asia. At the. Regional Review Meeting on Immunization
Message from Dr Samlee Plianbangchang Regional Director, WHO South-East Asia At the Regional Review Meeting on Immunization 19-23 July 2010 WHO/SEARO, New Delhi Regional Review Meeting on Immunization
More informationAPEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006
APEC Ministerial Meeting on Avian and Influenza Pandemics Da Nang, Viet Nam, 4-6 May 2006 APEC Action Plan on the Prevention and Response to Avian and Influenza Pandemics 1. Many APEC economies have been
More informationTABLE OF CONTENTS. Peterborough County-City Health Unit Pandemic Influenza Plan Section 1: Introduction
TABLE OF CONTENTS 1. Introduction...1-2 1.1 Background...1-2 1.2 Why Does Peterborough County and City Need a Plan for Influenza Pandemic?...1-2 1.3 About Influenza...1-3 1.4 When Does Influenza Become
More informationChanging the prevention paradigm for the future what Europe can do
November 3rd, 2014 Honorable Beatrice Lorenzin, Minister of Health of Italy Italian Presidency of the EU Council Conference/Meeting The State of Health of Vaccination in the EU: where do we stand, where
More informationSECOND FAO/OIE REGIONAL MEETING ON AVIAN INFLUENZA CONTROL IN ASIA Ho Chi Minh City, Vietnam, February 2005
SECOND FAO/OIE REGIONAL MEETING ON AVIAN INFLUENZA CONTROL IN ASIA Ho Chi Minh City, Vietnam, 23-25 February 2005 OIE Address for the Opening Session (Dr T. Fujita, OIE Representative, OIE Regional Representation
More informationGUIDE TO INFLUENZA PANDEMIC PREPAREDNESS FOR FAITH GROUPS
GUIDE TO INFLUENZA PANDEMIC PREPAREDNESS FOR FAITH GROUPS Ontario Ministry of Health and Long-Term Care May 2006 Guide to Influenza Pandemic Preparedness for Faith Groups 1 Table of Contents 1.0 INTRODUCTION...
More informationIcelandic Pandemic Influenza Preparedness Plan. Issue 2, 2016
English Abstract Icelandic Pandemic Influenza Preparedness Plan. Issue 2, 2016 Contents Introduction... 2 Objectives of the Icelandic Pandemic Influenza Preparedness Plan:... 2 The Phases of Disaster,
More informationPreparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do
Preparing For Pandemic Influenza: What the CDC and HHS Recommend You Can Do Based on current data and information from the Centers for Disease Control (CDC) and the U.S. Department Health and Human Services
More informationGSK s Candidate Influenza A (H5N1) Virus Monovalent Vaccine
GSK s Candidate Influenza A (H5N1) Virus Monovalent Vaccine Regulatory Pathway for Licensure VRBPAC, February 29, 2012 Katalin Abraham, Director, US Regulatory Affairs GSK Biologicals GSK s Influenza Vaccines
More informationIssue No.1, December 2010 From the WHO Regional Office for Europe, WHO/EURO -
Issue No.1, December 2010 From the WHO Regional Office for Europe, WHO/EURO - http://www.euro.who.int/ Flu Focus is an e-magazine published by the WHO Regional Office for Europe that covers recent developments,
More informationPOSITION DESCRIPTION. Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) PURPOSE OF POSITION DESCRIPTION
POSITION DESCRIPTION Position Title: Location: Research Coordinator Clinical Trials National Secretariat, Brisbane-based Employment Status: Maternity Leave Contract 5 months (Jan-May 2018) Reporting Relationships:
More informationDirected Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups
Directed Enhanced Service (DES) for H1N1 Vaccination Programme JCVI priority groups October 2009 Introduction NHS Employers and the General Practitioners Committee (GPC) of the BMA have agreed arrangements
More informationThe use of antivirals to reduce morbidity from pandemic influenza
The use of antivirals to reduce morbidity from pandemic influenza Raymond Gani, Iain Barrass, Steve Leach Health Protection Agency Centre for Emergency Preparedness and Response, Porton Down, Salisbury,
More informationInfluenza A H1N1 Swine Flu Update:
Influenza A H1N1 Swine Flu Update: Pandemic Influenza Planning for the Workplace Current as of August 2009 Georgia Tech OSHA Consultation Program This course does not necessarily reflect the views or policies
More informationHealth Task Force Workplan
2006/SOM 3/HTF/021 Agenda Item: VI Health Task Force Workplan 2006-2007 Purpose: Information Submitted by: Chair Health Task Force Meeting Da Nang, Viet Nam 14 15 September 2006 APEC HEALTH TASK FORCE
More informationStrengthening regional health security: Emerging diseases and disaster preparedness and response
TWELFTH PACIFIC HEALTH MINISTERS MEETING PIC12/T6 Rarotonga, Cook Islands 21 August 2017 28 30 August 2017 ORIGINAL: ENGLISH Strengthening regional health security: Emerging diseases and disaster preparedness
More informationChallenges and solutions in making evidence-based national vaccination policies and recommendations
Challenges and solutions in making evidence-based national vaccination policies and recommendations Philippe Duclos, WHO 15th ADVAC, Les Pensières, Veyrier du Lac, May 19, 2014 Developing evidence-based
More informationMaintaining a Safe and Adequate Blood Supply in the Event of Pandemic Influenza. Guidelines for National Blood Transfusion Services
Maintaining a Safe and Adequate Blood Supply in the Event of Pandemic Influenza Guidelines for National Blood Transfusion Services 19 May 2006 1 Rationale Current global concern that an occurrence of pandemic
More informationWORLD HEALTH ORGANIZATION
WORLD HEALTH ORGANIZATION FIFTY-FOURTH WORLD HEALTH ASSEMBLY A54/9 Provisional agenda item 13.3 2 April 2001 Global health security - epidemic alert and response Report by the Secretariat INTRODUCTION
More informationBrief history of the development of the Framework on Sharing influenza viruses and access to vaccines and other benefits
Brief history of the development of the Framework on Sharing influenza viruses and access to vaccines and other benefits The Intergovernmental (IGM) Process Since the late 1940's, WHO has coordinated a
More informationConflict of Interest and Disclosures. Research funding from GSK, Biofire
Pandemic Influenza Suchitra Rao, MBBS, Assistant Professor, Pediatric Infectious Diseases, Hospital Medicine and Epidemiology Global Health and Disasters Course, 2018 Conflict of Interest and Disclosures
More informationREGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC. second edition
REGIONAL ALLIANCE FOR NATIONAL REGULATORY AUTHORITIES FOR VACCINES IN THE WESTERN PACIFIC second edition World Health Organization 2014 The designations employed and the presentation of the material in
More informationB - Planning for a Turkey Flu Pandemic
RA 2014-15 Pandemic risk: B - Planning for a Turkey Flu Pandemic 8 B - Planning for a Turkey Flu Pandemic You are employed by the government OR service and your team has been asked to provide OR support
More informationHC 963 SesSIon november Department of Health. Young people s sexual health: the National Chlamydia Screening Programme
Report by the Comptroller and Auditor General HC 963 SesSIon 2008 2009 12 november 2009 Department of Health Young people s sexual health: the National Chlamydia Screening Programme 4 Summary Young people
More information5 th Islamic Conference of Health Ministers. Resolution. Istanbul, Turkey November 2015 (5-7 Safar 1437H)
5 th Islamic Conference of Health Ministers Resolution Istanbul, Turkey 17-19 November 2015 (5-7 Safar 1437H) Draft Resolution No. 2/5-ICHM On Healthy Life Style, Prevention and Control of Communicable
More informationObama declares H1N1 national emergency
www.breaking News English.com Ready-to-use ESL/EFL Lessons by Sean Banville 1,000 IDEAS & ACTIVITIES FOR LANGUAGE TEACHERS The Breaking News English.com Resource Book http://www.breakingnewsenglish.com/book.html
More informationWhat needs to happen in England
What needs to happen in England We ve heard from over 9,000 people across the UK about what it is like to live with diabetes and their hopes and fears for the future. Over 6,000 of them live in England;
More informationBeing Ready for the Next Pandemic: Expanded Access to Pandemic Vaccines
Being Ready for the Next Pandemic: Expanded Access to Pandemic Vaccines Coordination Between Public Health and Pharmacies Sam Graitcer, MD Immunization Services Division, NCIRD CDC Pandemic Influenza Vaccine
More informationInfluenza: A recap of the season
Influenza: A recap of the 2012 2013 season March 22, 2013 Debra Blog MD, MPH Director Division of Epidemiology What are we going to talk about The 2012 13 Influenza Vaccine Influenza Activity and Surveillance
More informationAn example of intersectoral collaboration: the EU model. European Commission Health and Consumers Directorate-General (DG SANCO)
An example of intersectoral collaboration: the EU model European Commission Health and Consumers Directorate-General (DG SANCO) The European Union: 27 Member States 3 Candidate Countries European Institutions
More information